Hall, Bradford E.
Macdonald, Emma
Cassidy, Margaret
Yun, Sijung
Sapio, Matthew R.
Ray, Pradipta
Doty, Megan
Nara, Pranavi
Burton, Michael D.
Shiers, Stephanie
Ray-Chaudhury, Abhik
Mannes, Andrew J.
Price, Theodore J.
Iadarola, Michael J.
Kulkarni, Ashok B.
Funding for this research was provided by:
National Institutes of Health, USA (ZIA-DE-000664-24, ZIA-DE-000664-24, ZIA-DE-000664-24, ZIA-DE-000664-24, ZIA-DE-000664-24, ZIA-DE-000664-24)
NIH Clinical Center (1ZIACL090033-08 and 1ZIACL090035-07, 1ZIACL090033-08 and 1ZIACL090035-07, 1ZIACL090033-08 and 1ZIACL090035-07, 1ZIACL090033-08 and 1ZIACL090035-07, 1ZIACL090033-08 and 1ZIACL090035-07)
Office of Extramural Research, National Institutes of Health (NS111929, NS111929, NS111929, NS111929)
National Institutes of Health
Article History
Received: 8 October 2021
Accepted: 25 February 2022
First Online: 18 March 2022
Competing interests
: All authors have declared that no conflict of interest exists. TJP is a co-founder of Doloromics, a company developing novel pain therapeutics. Doloromics played no role in this study.